Alberta judge extends order freezing separatist lawyer’s assets in legal dispute with First NationJuly 16, 2026
Celcuity’s First-in-Class Drug Gets FDA Approval in Most Common Type of Breast CancerNews DeskJuly 15, 20260 Advanced cases of breast cancer now have a new FDA-approved treatment option, a Celcuity drug whose first-in-a class approach could…
Where Patient Education Breaks Down in Breast Cancer CareNews DeskJune 25, 20260 I am alive because I pushed for answers. But I am living with consequences no one prepared me for. When…
New FDA Nod Keeps Gilead Drug Competitive With AstraZeneca & Daiichi in Breast CancerNews DeskJune 25, 20260 The FDA has expanded the approval of a targeted Gilead Sciences therapy as a new first-line treatment for triple-negative breast…